North, tell us, if you can, WHEN do you think all of this research from these prestigious institutions is going to result in any real value to shareholders. By this I am not referring to perceived value here on this forum but real value in the share price. To be clear, I am looking for a real time estimate, no hedging. Your opinion. Six months, one year, three years, five years, twenty years? If you can. Some of us won't live for ever unfortunately.
I'll add to your point... Tell us all the impressive institutions that have been involved with bavi over the last ~14 years? I'll be the first to acknowledge it's a very long list. the problem is that all those years and all those organizations and all that research yielded results that were at best unimpressive which is why even the company admits its failure by refocusing with AVID.
Note the missing paragraph in today's PR? It used to start with something like "Peregrine is pursuing the licensing or sale of its proprietary R&D assets, including its lead immunotherapy candidate, bavituximab....."
As I've expected you'll be seeing and reading and hearing less and less about Bavi over time and it's already begun. Soon to enter the realm of "Cotaraland".
What will Bavi fetch in a deal? Everyone "realistic" already knows. ZIPPO or breadcrumbs are the only possibilities. But heck, I've only been 100% right about this stock for about 14 years.
News 
Market Data 
Discover 
AI
